Market Tracker

07/31 6:01pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

2.64
Delayed Data
As of Jul 31
 +0.02 / +0.76%
Today’s Change
0.33
Today|||52-Week Range
5.75
+560.00%
Year-to-Date

Today’s Trading

Previous close2.62
Today’s open2.64
Day’s range2.40 - 2.64
Volume1,160,243
Average volume (3 months)1,110,530
Market cap$98.2M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+7.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-12.19%
P/E ratioNM
Price/Sales4.78
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PULMPulmatrix Inc+0.26+3.98%
RNNRexahn Pharmaceutica...+0.02+3.79%
OGENOragenics Inc+0.40+18.02%
PVCTProvectus Biopharmac...+0.01+1.98%
Data as of 4:01pm ET, 07/31/2015

Financials

Next reporting dateAugust 14, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$2.9M
Annual profit (last year)-$4.6M
Net profit margin-155.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quebec

Forecasts